NEWTOWN, Pa.--InforMax and AxCell Biosciences have completed a prototype software tool that enables visualization of AxCell's in-house database of protein-protein interactions. The two companies had agreed last December to develop technology that would allow them to jointly market the database as part of InforMax's enterprise bioinformatics product, GenoMax.

As part of the deal, InforMax also installed GenoMax at AxCell's laboratory here to help AxCell identify protein domains and ligands it uses for high throughput protein-protein interaction measurements.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.